Scientists probe why gastric bypass causes dangerous blood sugar drops

NCT ID NCT00992901

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at how gastric bypass surgery affects insulin and blood sugar control, focusing on gut hormones and nerve signals. Researchers will compare three groups: people who had the surgery and now have severe low blood sugar, those who had the surgery without symptoms, and healthy volunteers without surgery. Participants receive short-acting drugs to measure how their bodies respond, helping explain why some develop life-threatening hypoglycemia years after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Exendin-(9-39), Atropine, GLP-1 and GIP
What this could lead to
If successful, this could clarify why some people develop dangerous low blood sugar after gastric bypass, pointing toward better prevention or treatment.
What could go wrong
This is an early-phase observational study, not testing a new treatment. Results may not lead to direct therapies, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERINSULINEMIC HYPOGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • South Texas Veterans Health Care System

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Texas Diabetes Institute - University Health System

    RECRUITING

    San Antonio, Texas, 78207, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.